Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol

By sjmartinez • November 29, 2024

Newell-Price J, Fleseriu M, Pivonello R, Feelders RA, Gadelha MR, Lacroix A, Witek P, Heaney AP, Piacentini A, Pedroncelli AM, Biller BMK. Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol. J Endocr Soc. 2024 Nov 12;9(1):bvae201. doi: 10.1210/jendso/bvae201. PMID: 39610378; PMCID: PMC11604051.

Tags: cortisol normalization, Cushing disease, Endocrinology, hypercortisolism, long-term treatment, osilodrostat, Publications

Related Posts

Ketogenic diet mediates intestinal tumorigenesis through lipids not ketones

Shay JES, Chi F, Tzouanas CN, Han S, Zhang X, Ten Hoeve J, Williams KJ, Neptun S, Sever T, Fuentes I, Bhatia SN, Calibasi-Kocal G,[...]

A Spanish-language educational intervention to enhance diabetes outcomes among existing continuous glucose monitor users in a federally qualified health care center

Tavares M, Khoshbin K, Solorzano W, Scarlett L, Santana C, Lopez R, Villanueva GP, Escobar B, Mangual KS, Pavlish C, Bush NJ, Moin T, Everett[...]

Enhancing mental and physical health of women through engagement and retention (EMPOWER) 3.0 QUERI: study protocol for a cluster-randomized hybrid type 3 implementation-effectiveness trial

Hamilton AB, Farmer MM, Bean-Mayberry B, Moin T, Lang A, Adams L, Chanfreau C, Fenwick K, Canelo I, Oberman R, Finley EP; EMPOWER 3.0 QUERI[...]